Immune checkpoint inhibitor therapy and elevated levels of C-reactive protein associated with COVID-19 aggravation in patients with lung cancer

• Asıl Yazarlar: Masatoshi Maki (Yazar), Ryo Takada (Yazar), Akihiko Taniguchi (Yazar), Naoyuki Nomura (Yazar), Seiichiro Kuramoto (Yazar), Yuki Chiko (Yazar), Toshiaki Okada (Yazar), Seiji Saito (Yazar), Koji Tamura (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: BMC, 2022-11-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Abstract Background COVID-19 has become a significant health threat and a primary healthcare concern among the most vulnerable patients with cancer. Patients with COVID-19 who have lung cancer are at great risk and need careful monitoring if they are affected. This study aimed to investigate the cli...